Table 2 Age- and sex-adjusted prevalence of CKD, and risk factors in the study population (n = 1353, Males = 595; Females =758)
Characteristic | Total(%) | Male (%) | Female (%) | X2 | P value |
|---|---|---|---|---|---|
CKD eGFR < 60 ml/min/1.73m2, | 11.8 | 9.5 | 14.1 | 16.6 | <  0.001 |
Stage 3 (estimated GFR 30 to 59) | 9.5 | 6.9 | 11.6 | 14.79 | < 0.001 |
Stage 4 (estimated GFR 15–29) | 1.3 | 1.29 | 1.4 | 0.79 | 0.373 |
Stage 5 (estimated GFR < 15) | 1.0 | 1.1 | 0.9 | 0.59 | 0.367 |
Age | |||||
  < 30 | 10.5 | 9.6 | 10.9 | 4.89 | 0.027 |
 30–39 | 8.8 | 6.98 | 10.9 | 5.92 | 0.015 |
 40–49 | 14.7 | 11.4 | 17.6 | 5.73 | 0.017 |
  > 50 | 11.7 | 19.5 | 14 | 4.17 | 0.041 |
Albuminuria | |||||
  ≥ 30 mg/dL | 7.1 | 7.3 | 6.9 | 0.28 | 0.598 |
Hypertension | |||||
 SBP ≥140 mmHg+/or DBP ≥90 mmHg | 23.7 | 25.2 | 23.4 | 0.306 | 0.442 |
Diabetes | |||||
 FBS ≥7.0 mmol/L | 4.1 | 3.8 | 4.5 | 0.869 | 0.351 |
Overweight and obesity | |||||
 25 to 29.9 kg/m2, n (%) | 15.3 | 15 | 16 | 0.804 | 0.459 |
  ≥ 30 kg/m2, n (%) | 8.7 | 5.2 | 11.8 | 39.72 | < 0.001 |